- Lobbying
- Lobbying by Dream Medical Group
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Rich Meade | 1994-96: Legislative Director, Rep. Jim Nussle; 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives |
Zack Marshall | May 2008-2010: Legislative Correspondent, Rep. Jim Cooper; 2010-2012: Legislative Assistant, Rep. Jim Cooper; 2012-March 2014: Senior Legislative Assistant, Rep. Jim Cooper; March 2014 - January 2019: Legislative Director, Rep. John Yarmuth |
Emily Katz | 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH |
Charles Black | n/a |
R. Scott Pastrick | n/a |
Mitchell Vakerics | n/a |
Pamela Turner | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Amendment
Lobbying Issues
Agencies Lobbied
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medical equipment.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate